Table 1.
Cohort Baseline Characteristics
| PCOS (n = 8) | OC (n = 22) | P-value | |
|---|---|---|---|
|
| |||
| Demographics | |||
|
| |||
| Age (years) | 22.9 (18.1 – 29.1) | 26.8 (18.6 – 36.6) | 0.22 |
|
| |||
| Race | 0.66 | ||
| White | 5 (62.5%) | 17 (77.3%) | |
| Black | 1 (12.5%) | 2 (9.1%) | |
| Asian/Pacific Islander | 2 (25%) | 3 (13.6%) | |
|
| |||
| Ethnicity | 0.39 | ||
| Hispanic | 1 (12.5%) | 7 (31.8%) | |
| Non-Hispanic | 7 (87.5%) | 15 (68.2%) | |
|
| |||
| Biometric Characteristics | |||
|
| |||
| Weight (kg) | 72.0 (54.8 – 119.3) | 56.1 (46.7 – 85.6) | 0.10 |
|
| |||
| Body Mass Index | 29.4 (21.3 – 36.3) | 22.9 (18.0 – 32.5) | 0.05 |
|
| |||
| Antral Follicle Count | 59.5 (31 – 76) | 24.5 (12 – 52) | <0.01 |
|
| |||
| Basal Hormone Values | |||
|
| |||
| Follicle Stimulating Hormone (IU/L) | 5.0 (4.7 – 9.3) | 7.0(3.6 – 10.9) | 0.14 |
|
| |||
| Luteinizing Hormone (IU/L) | 11.3 (4.3 – 15.8) | 4.8 (2.2 – 9.5) | <0.01 |
|
| |||
| Estradiol (pg/mL) | 78.6 (40.9 – 141.7) | 66.2 (29.7 – 148.8) | 0.34 |
|
| |||
| Total Testosterone (ng/dL) | 39.6 (21.6 – 56.8) | 23.5 (12.1 – 36.0) | <0.01 |
|
| |||
| 17-hydroxyprogesterone (ng/mL) | 1.0(0.7 – 1.6) | 0.8 (0.5 – 1.5) | 0.19 |
|
| |||
| Antimüllerian Hormone (ng/mL) | 12.6 (8.1 – 38.7) | 6.1 (1.9 – 15.4) | <0.01 |
Number (n), median (range), and number (percent) for participant baseline characteristics. Bold type indicates significant differences between Ovulatory Control (OC) and Polycystic Ovary Syndrome (n=8) participants at baseline, with a p-value < 0.05.